Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
06/2014
06/24/2014US8759335 Modulators of ATP-binding cassette transporters
06/24/2014US8759334 Compounds useful for the treatment of metabolic and inflammatory diseases
06/24/2014US8759332 Hepatitis C virus inhibitors
06/19/2014WO2014092514A1 Novel compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient
06/19/2014WO2014092066A1 Photoelectric conversion element
06/19/2014WO2014091958A1 Material for organic electroluminescent element, organic electroluminescent element, illumination device, and display device
06/19/2014US20140171661 Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
06/19/2014US20140171639 Trpm8 antagonists and their use in treatments
06/19/2014US20140171469 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
06/19/2014US20140171442 Alicyclic[c] benzopyrone derivatives and uses thereof
06/19/2014US20140171439 Inhibitors Of Histone Deacetylase
06/18/2014EP2743271A1 Pim kinase inhibitor and preparation method and use in medicinal manufacture thereof
06/18/2014EP2743268A2 Fused cyclic compounds as GPR40 receptor modulators
06/18/2014EP2743266A2 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon
06/18/2014EP2742041A1 Process for the preparation of benzohetero [ 1, 3]- diazole compounds disubstituted with heteoaryl groups
06/18/2014EP2742040A1 Indazole compounds, compositions and methods of use
06/18/2014EP2742027A1 N-thio-anthranilamide compounds and their use as pesticides
06/18/2014CN103874695A 2-pyridyloxy-4-nitrile orexin receptor antagonists
06/18/2014CN103874690A Hydrazide containing nuclear transport modulators and uses thereof
06/18/2014CN103874688A Herbicidal pyridazinone derivatives
06/18/2014CN103874687A Benzodioxepin-3-one compounds as dyes or as fluorescent emitters
06/18/2014CN103865524A Hole-type organic electroluminescent material and application thereof
06/18/2014CN103864795A Dithiolane-containing cis-anabasine compound and preparation method and application thereof
06/18/2014CN103864768A Ligustrazine stilbene derivatives as well as preparation method and application thereof
06/18/2014CN103864765A Benzoazepine derivative containing five-membered heterocycle as well as preparation method and application of derivative
06/18/2014CN103864754A Five-membered azole heterocycle compound, preparation method, drug composition and use thereof
06/18/2014CN103864737A Phenyl C-glucoside derivative containing deoxyglucose structure as well as preparation method and application thereof
06/18/2014CN103864735A Synthesis of novel 5-bromo-3(2H)-benzofuranone derivatives and application in antitumor drugs
06/18/2014CN103864734A Synthesis and application of novel 4,6-dihydroxy-3(2H)-benzofuranone derivatives
06/18/2014CN103864731A Synthetic method of furan lactonic ring compound containing quaternary carbon chiral center
06/18/2014CN103864658A Azacyclobutanone derivatives as well as preparation method and application thereof
06/18/2014CN102408416B Thiophene derivative for DNA detection and preparation method thereof
06/18/2014CN102408385B Preparation method of 2-substituent-2H-1,2,3-triazole derivative
06/18/2014CN102271516B Stable insecticide compositions and methods for producing same
06/18/2014CN101952275B Modulators for amyloid protein beta
06/18/2014CN101903372B Heteroaryl derivatives as orexin receptor antagonists
06/18/2014CN101405283B HIV inhibiting 5-amido substituted pyrimidines
06/17/2014US8754226 Piperidinyl-substituted lactams as GPR119 modulators
06/17/2014US8754210 Method for preparing 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl) derivative and intermediate used therein
06/17/2014US8754209 Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient
06/17/2014US8754122 Geminal dialkyl prostanoids
06/17/2014CA2699986C Anti-infective pyrimidines and uses thereof
06/17/2014CA2601979C 2,3 substituted pyrazine sulfonamides
06/17/2014CA2595848C Erastin and erastin binding proteins, and uses thereof
06/12/2014WO2014088290A1 Organic electroluminescent compounds and organic electroluminescent device comprising the same
06/12/2014WO2014088085A1 Pyridone compound
06/12/2014WO2014087165A1 Tankyrase inhibitors
06/12/2014WO2014086805A1 Pyridine-2-amides useful as cb2 agonists
06/12/2014WO2014086663A1 Substituted triazole and imidazole compounds
06/12/2014WO2014047662A3 Indazole derivatives and uses thereof
06/12/2014US20140163092 Chromone Inhibitors of S-Nitrosoglutathione Reductase
06/12/2014US20140163031 Substituted pyrazoles as n-type calcium channel blockers
06/12/2014US20140163009 Histone deacetylase inhibitors and compositions and methods of use thereof
06/12/2014US20140162997 Substituted pyrazoles as n-type calcium channel blockers
06/11/2014EP2740729A1 Quinazoline derivative, composition having the derivative, and use of the derivative in preparing medicament
06/11/2014EP2739614A1 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
06/11/2014EP2739609A1 Novel estrogen receptor ligands
06/11/2014CN103857680A Novel organic electroluminescent compounds and organic electroluminescent device using the same
06/11/2014CN103857675A Metalloenzyme inhibitor compounds
06/11/2014CN103857673A Novel organic electroluminescent compounds and organic electroluminescent device using the same
06/11/2014CN103857656A Enantionselective processes to insecticidal 3-aryl-3-trifluoromethyl-substituted pyrrolidines
06/11/2014CN103848825A Preparation method and application of sulfonium sugar natural product with inhibition activity on alpha-glucosidase and derivatives thereof
06/11/2014CN103848821A Spiro compound serving as hepatitis C inhibitor, drug composition and applications of spiro compound and drug composition
06/11/2014CN103848820A Spiro compound serving as hepatitis C inhibitor and applications thereof in drugs
06/11/2014CN103848818A Parallel ring compound serving as hepatitis C inhibitor, drug composition and applications of parallel ring compound and drug composition in drugs
06/11/2014CN103848814A Substituted indole ketone derivative as tyrosine kinase inhibitor
06/11/2014CN103848792A 4,4-disubstituted-dihydro-2-(1H)-quinazolinone as well as synthetic method and use thereof
06/11/2014CN103130766B Piperine hydrazone or acylhydrazone or sulfonyl hydrazone derivative substances and application for preparing a botanical insecticide
06/11/2014CN102659770B Double tetrathiofulvene compound containing pyridyl and preparation method thereof
06/11/2014CN102596936B Antiviral compounds
06/11/2014CN102292330B Novel microbiocides
06/11/2014CN102115468B Synthesis method of 2, 5-disubstituted thiophene compound
06/10/2014US8748597 2,4-pyrimidinediamine compounds and their uses
06/10/2014US8748459 Pyridinoylpiperidines as 5-HT1F agonists
06/10/2014US8748442 sGC stimulators
06/10/2014US8748440 Quinazolinone modulators of nuclear receptors
06/10/2014CA2602474C Hydrogenated benzo (c) thiophene derivatives as immunomodulators
06/05/2014WO2014085607A1 Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
06/05/2014WO2014084407A1 Dihydropyrone compounds and herbicides comprising the same
06/05/2014WO2014084323A1 Transparent electrode, and electronic device
06/05/2014WO2014084170A1 Transparent electrode, electronic device, and organic electroluminescence element
06/05/2014WO2014082889A1 Novel imidazolines as dual inhibitors of mdm2 and mdmx
06/05/2014WO2014082379A1 Spiro ring compound as hepatitis c virus (hcv) inhibitor and uses thereof field of the invention
06/05/2014US20140155447 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents
06/05/2014US20140155415 Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes
06/05/2014US20140155407 Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
06/05/2014US20140155401 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands
06/05/2014US20140155370 Nuclear transport modulators and uses thereof
06/05/2014US20140155264 N-Thio-Anthranilamide Compounds and Their Use as Pesticides
06/04/2014EP2736897A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
06/04/2014EP2736896A1 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors
06/04/2014EP2736894A1 Method for producing benzo[b]thiophene compound
06/04/2014EP2736887A1 Hydrazide containing nuclear transport modulators and uses thereof
06/04/2014EP2736885A2 Cysteinyl leukotriene antagonists
06/04/2014EP2736881A1 Process for producing n-(hetero)arylazoles
06/04/2014CN1585772B Chemokine receptor antagonists and methods of use thereof
06/04/2014CN103842355A Metalloenzyme inhibitor compounds
06/04/2014CN103842344A Cystelinyl leukotriene antagonists based on quinolin, quinoxaline or benz[c]thiazole
06/04/2014CN103842341A Novel estrogen receptor ligands
06/04/2014CN103842339A Carbazole derivatives for organic electroluminescence devices
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 523